Daurisoline-d2

Daurisoline-d2 is the deuterium labeled Daurisoline (HY-N0221) . Daurisoline is a bis-benzylisoquinoline alkaloid that can be isolated from Menispermum dauricum and Rhizoma Menispermi. Daurisoline exerts a blocking effect on hERG and has antiarrhythmic effects. Daurisoline is a potent autophagy blocker that can be used for the research of cancer[1][2].

Product Specifications

Product Name Alternative

(R, R) -Daurisoline-d2

UNSPSC

12352005

Target

Autophagy; Isotope-Labeled Compounds; Potassium Channel

Type

Isotope-Labeled Compounds

Related Pathways

Autophagy; Membrane Transporter/Ion Channel; Others

Applications

COVID-19-immunoregulation

Field of Research

Cancer

Solubility

10 mM in DMSO

Smiles

OC1=C([2H])C2=C(C=C1OC)CCN(C)[C@@H]2CC3=CC([2H])=C(O)C(OC4=CC=C(C[C@H]5N(C)CCC6=C5C=C(OC)C(OC)=C6)C=C4)=C3

Molecular Formula

C37H40D2N2O6

Molecular Weight

612.75

References & Citations

[1]Liu Q, et al. Effect of daurisoline on HERG channel electrophysiological function and protein expression. J Nat Prod. 2012 Sep 28;75 (9) :1539-45.|[2]Wu MY, et al. Natural autophagy blockers, dauricine (DAC) and daurisoline (DAS), sensitize cancer cells to camptothecin-induced toxicity. Oncotarget. 2017 Sep 8;8 (44) :77673-77684.